Lv1
40 积分 2025-06-22 加入
Challenges and opportunities in NASH drug development
9天前
已完结
Therapeutic landscape of metabolic dysfunction-associated steatohepatitis (MASH)
9天前
已完结
Effect of Intensive vs Standard Blood Pressure Control on Probable Dementia
1个月前
已完结
Changes in Alzheimer Disease Blood Biomarkers and Associations With Incident All-Cause Dementia
1个月前
已完结
Association of Midlife to Late-Life Blood Pressure Patterns With Incident Dementia
1个月前
已完结
Blood pressure reduction and all-cause dementia in people with uncontrolled hypertension: an open-label, blinded-endpoint, cluster-randomized trial
1个月前
已完结
2024 ESC Guidelines for the management of elevated blood pressure and hypertension
5个月前
已完结
Epidemiological characteristics and management of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis in China: A narrative review
5个月前
已完结
Current status and future trends of the global burden of MASLD
6个月前
已完结
Steatotic liver disease
6个月前
已完结
皖公网安备34019202002308
